Please find all related articles below.
The Health Action International (HAI) Europe (1), and the Trans-Atlantic Consumer Dialogue (2) are co-ordinating a lunch debate on the subject of “Opening up medical research data for an ethical and efficient EU policy.”
The debate will feature Prof. Dr. Wolf-Dieter Ludwig, Chairman at the Drug Commission of the German Medical Association, and Dr. Peter G°tzsche, Director of the Nordic Cochrane Centre as well as responses from the European Commission, the European Ombudsman and (...)
On 15 May 2012, EPHA co-organised an event in collaboration with our member the European Society of Intensive Care Medicine (ESICM) at the European Parliament. Cristian Buşoi MEP (ALDE, Romania) hosted and moderated a policy debate on the contribution of ’’intensivists’’ to better patient outcomes and health systems, tied to the launch of a two-day exhibition to promote the ESCIM’s LIFE-PRIORITY campaign.
The overall aim of the policy debate, entitled (...)
The European Medicines Agency (EMA) has published the final reflection paper on ethical and good clinical practice aspects of clinical trials of medicinal products for human use. Conducted outside of the EU/EEA and submitted in marketing authorisation, it produced several applications to the EU regulatory authorities.
Entering into force on 1 May 2012, the EMA reflection paper aims to strengthen existing processes to provide assurance to regulators and stakeholders that clinical trials (...)
HAI Europe, EPHA member, and TACD (Trans-Atlantic Consumer Dialogue) launched their new Policy Paper. The report is entitled ’Time for the EU to lead on innovation: EU policy opportunities in biomedical innovation and the creation of public knowledge goods today.’ The paper is a call for EU-funded research and development to open needs-driven innovation to support affordable access to biomedical knowledge and public goods.
Read HAI and TACD paper: Time for the EU to lead on (...)
On 29 February 2012, the European Commission proposed several Innovation Partnerships in order to meet key challenges facing our society, in areas that are crucial to growth and jobs: one of these be sustainable agricultural productivity. The Commission claims a more concerted innovation effort across the public and private sector of agriculture and food production, in order to improve quality of life and position Europe as a global leader.
The Commission’s new European Innovation (...)
EPHA member - Cancer Research UK - presents its policy recommendations to reform the Clinical Trials Directive.
A new policy briefing by Cancer Research UK, ’’Supporting research, protecting patients’’ has been launched during a meeting in the European Parliament.
The briefing contains a number of key recommendations to reform the Clinical Trials Directive, amongst them:
option of coordinated assessment procedure for multi-national clinical trials
Researchers at the Tobacco Control Research Group have shown in a paper published in the British Medical Journal how the Tobacco Industry attempted to use the German government to undermine the WHO Framework Convention on Tobacco Control (FCTC).
Germany has been identified as one of a few high-income countries that opposed a strong Framework Convention on Tobacco Control (FCTC). A group of researchers has examined the role that the tobacco industry played in influencing the German (...)
The 5th European Public Health Conference will take place in Malta in November 2012. The overall theme will focus on "All Inclusive Public Health". The call for abstracts opens on the 1st of February 2012. Information on submission and deadlines is available below.
The 5th European Public Health Conference aims to offer a means for exchanging information and a platform for debate to researchers, policy makers, and practitioners in the field of public health and health services research. (...)
EPHA answered the DG Research consultation on the European Research Area. In the EPHA response, the role of CSOs and the importance of health research are highlighted.
In its position, EPHA highlights the following points:
Research and innovation should address the most pressing societal challenges benefiting all members of society;
Energy and climate change along with population ageing and health are some of our biggest societal challenges and must be addressed by the ERA to (...)
€31.7 billion will be allocated to tackling the major issues affecting the lives of European citizens and €8.5 billion euros are earmarked to health.